Medifacts International Wins $2.7 Million Study with Top Ten Pharmaceutical Company
ROCKVILLE, Md.--(BUSINESS WIRE)--MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiac diagnostic services, today announced the award of a $2.7 million contract with a top ten pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large late stage clinical trial.